Easton Pharmaceuticals - M&A Summary and Business Overview

Life ScienceCompany

Easton Pharmaceuticals M&A Summary

Easton Pharmaceuticals has acquired 1 company.

The Company’s most targeted sectors include life science (100%).

Easton Pharmaceuticals Business Overview

Where is Easton Pharmaceuticals headquartered?

Easton Pharmaceuticals is headquartered in Toronto, Ontario.

What sector is Easton Pharmaceuticals in?

Easton Pharmaceuticals is a life science company.

When was Easton Pharmaceuticals founded?

Easton Pharmaceuticals was founded in 1997.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1

Easton Pharmaceuticals

Easton Pharmaceuticals, Inc.

Brockhouse Road,
Toronto, Ontario M3J3C6
Canada,
(647) 362-5700
www.eastonpharmaceuticalsinc.com

Easton Pharmaceuticals is a diversified specialty pharmaceutical company involved in various pharmaceutical sectors and new growing industries. The Company previously developed and owned an FDA-approved wound-healing drug and currently owns topically delivered drugs to treat cancer and other therapeutic products to treat various conditions that are all in various stages of development and approval. Easton has partnered with BMV Medica SA de C.V. and together, own the exclusive distribution rights in Mexico and Latin America for patented women's diagnostic and preventative care products from CommonSense of Israel, along with two generic cancer drugs, Paclitaxel and Docetaxel from BioLyse Pharma of St. Catherine's Ontario, Canada. The company's list of woman's diagnostic, treatment and preventative care products include, Gynofit, licensed from a Swiss based manufacturer, VS-Sense and AmnioSense, both patented products that are licensed from Israel based CommonSense. Easton has entered into a distribution agreement with Europe based Gedeon Richter for Gynofit. Easton Pharmaceuticals was founded in 1997 and is based in Toronto, Canada.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
iBliss, Inc. 2017-01-23 - Add-on Acquisition
Toronto, Ontario
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) - - -
Total 1 - - -

By Geo

State/Country Buy Value Sell Value
Canada 1 - - -
  Ontario 1 - - -
Total 1 - - -

 Subscribe to unlock this and 208,718
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.